Newcastle disease virus enhances the growth-inhibiting and proapoptotic effects of temozolomide on glioblastoma cells in vitro and in vivo
/in Glioblastoma, International Publications, Newcastle Disease VirusImmunotherapeutic strategies for treatment of hepatocellular carcinoma with antigen-loaded dendritic cells: in vivo study
/in Dendritic Cells, Hepatocellular Carcinoma, International PublicationsLow-dose cyclophosphamide depletes circulating naïve and activated regulatory T cells in malignant pleural mesothelioma patients synergistically treated with dendritic cell-based immunotherapy
/in Dendritic Cells, International Publications, Malignant Pleural MesotheliomaHigh-grade glioma associated immunosuppression does not prevent immune responses induced by therapeutic vaccines in combination with T depletion
/in Dendritic Cells, Glioblastoma, International PublicationsDendritic cell vaccines for high-grade gliomas
/in Dendritic Cells, Glioblastoma, International PublicationsA novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia
/in Acute Leukemia, Dendritic Cells, International PublicationsVitamin D deficiency in head and neck cancer patients – prevalence, prognostic value and impact on immune function
/in International Publications, MicronutrientsRecombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells
/in International Publications, Newcastle Disease Virus, Thyroid CancerSystematic Review of Intravenous Ascorbate in Cancer Clinical Trials
/in International Publications, Micronutrients
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer